Supernus Pharmaceuticals Inc
About
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
Feb 24 2026
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
Feb 23 2026
Supernus Pharmaceuticals to Participate in March Investor Conferences
Feb 12 2026
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
Dec 3 2025
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
Financials
Revenue
$718.95 M
Market Cap
$2.91 B
EPS
-0.68